Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Microbiol.

Sec. Microorganisms in Vertebrate Digestive Systems

Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1597145

This article is part of the Research TopicNew Progress on the Role of Gut Microbiota in the Incidence and Prevention of Liver DiseasesView all 17 articles

Analysis of Gut and Circulating Microbiota Characteristics in Patients with Liver Cirrhosis and Portal Vein Thrombosis

Provisionally accepted
Ping  QiPing Qi1,2xu  xu yangxu xu yang1,2kai  cun wangkai cun wang1wei  sangwei sang1wei  zhangwei zhang1yun  baiyun bai1*
  • 1Department of Agedness Gastroenterology, Hebei General Hospital, Shijiazhuang, China
  • 2Graduate School, Hebei North University, Zhangjiakou, Hebei Province, China

The final, formatted version of the article will be published soon.

Background:Portal vein thrombosis (PVT) is a common and serious complication of liver cirrhosis, often associated with worsened prognosis and increased risk of hepatic decompensation. The role of gut and circulating microbiota in its pathogenesis remains unclear.We enrolled cirrhotic patients with PVT(n=17) and cirrhotic patients without PVT (n=25). Fecal and peripheral blood samples were collected from all; portal vein samples were obtained from 16 patients undergoing TIPS. 16S rRNA sequencing was performed on fecal, peripheral blood, and portal venous blood samples to compare the diversity, structural differences, key microbial taxa, and characteristic variations of gut and circulating microbiota between cirrhotic patients with and without PVT.Results:1.Gut microbiota showed no α-diversity difference between groups, but β-diversity differed significantly. PVT patients had increased Gram-negative bacteria (such as Shigella-Escherichia) and decreased SCFA-producing taxa. 2.Compared with peripheral vein microbiota,portal vein microbiota showed significantly higher α-and β-diversity in cirrhotic patients with PVT, with Massilia enriched. 3.Portal microbiota had the highest diagnostic value for PVT (AUC = 0.95). 4.The tPVT group had more portal-feces shared genera than the tNPVT sgroup (49 vs. 29). Portal-peripheral-feces shared taxa were predominantly LPS-producing Gram-negative bacteria such as Shigella-Escherichia and Klebsiella.5.Most bacterial genera in the portal vein showed significant positive correlations with LPS and FⅧ in the portal vein. Genera such as Faecalibacterium, Eubacterium_hallii_group, Ruminococcus, Agathobacter, Bacteroides, and Romboutsia were significantly negatively correlated with Child-Pugh scores. Faecalibacterium, Eubacterium_hallii_group, Alistipes, Ruminococcus, Agathobacter, Bacteroides, Blautia, and Subdoligranulum were significantly negatively correlated with MELD scores. Ruminococcus and Agathobacter were significantly negatively correlated with D-Dimer, while Subdoligranulum showed significant positive correlations with LPS and FⅧ in the portal vein. Conclusions:Intestinal dysbiosis and translocation in cirrhotic patients with PVT lead to differential changes in the portal and peripheral circulatory microbiomes. This may contribute to the formation of PVT by inducing endotoxemia and systemic inflammation, providing a new microbiological perspective on the pathogenesis of cirrhosis-related PVT through the gut-liver axis.

Keywords: Liver Cirrhosis, Portal vein thrombosis, Gut Microbiota, circulating microbiota, microbial translocation

Received: 21 Mar 2025; Accepted: 13 May 2025.

Copyright: © 2025 Qi, yang, wang, sang, zhang and bai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: yun bai, Department of Agedness Gastroenterology, Hebei General Hospital, Shijiazhuang, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.